KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,526 | -25.1% | 81,736 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $146,307 | -38.8% | 81,736 | +33.1% | 0.00% | -40.0% |
| Q1 2023 | $238,885 | +3.4% | 61,410 | +55.0% | 0.01% | -16.7% |
| Q3 2021 | $231,000 | -2.9% | 39,622 | +71.8% | 0.01% | -25.0% |
| Q2 2021 | $238,000 | +7.7% | 23,067 | -37.4% | 0.01% | -60.0% |
| Q2 2019 | $221,000 | -79.0% | 36,827 | -79.6% | 0.02% | -80.4% |
| Q1 2019 | $1,053,000 | +203.5% | 180,355 | +784.1% | 0.10% | +240.0% |
| Q2 2018 | $347,000 | – | 20,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |